'BD to Dominate the Pre-filled Syringes Market to 2022' Visiongain Report Predicts

LONDON, February 16, 2012 /PRNewswire/ --

http://www.visiongain.com/Report/765/Top-Pre-Filled-Syringe-Manufacturers-Market-Outlook-2012-2022

A new report by visiongain predicts that Becton, Dickinson & Co (BD) will be the largest player in the pre-filled syringe market through to 2022. In 2012, that company's pre-filled syringe and related technology revenue will reach $1.14 billion, having grown with a CAGR of 7.0% since 2010. In the same period, the pre-filled syringe market will grow with a CAGR of 8.5%. These sales forecasts appear in Top Pre-Filled Syringe Manufacturers: Market Outlook 2012-2022, published in February 2012. Visiongain is a business information provider based in London, UK.

This new study profiles and analyses leading companies manufacturing and supplying pre-filled syringes to drug manufacturers. Visiongain estimates that in 2011 five companies accounted for the supply of more than 90% of glass pre-filled syringes to the pharmaceutical industry. As well as BD, leading companies in the market include Gerresheimer, Schott, MGlas and Nuova Ompi. A worldwide presence and the production of both glass and plastic pre-filled syringes mean that BD, Gerresheimer and Schott are the market leaders in 2012. Those companies have diversified product portfolios, appealing to a broad range of customers. Over the coming 10 years, those suppliers will benefit from increased demand for plastic syringes from pharma companies. This will be driven by the development of new biologics, vaccines and biosimilars, products stimulating the demand for stable, convenient injection systems for complex, sensitive medicines.

Richard Lang, a pharmaceutical industry analyst at visiongain, said: "The leading companies in the market at present can expect to retain their position over the coming decade. However, to gain market share they must follow a number of key market trends, including the increasing development of biologics and biosimilars and greater demands for safety in syringe products."

Visiongain's report also analyses the performance of leading manufacturers of pen injectors, autoinjectors and pre-filled syringe components. In 2010, autoinjectors and pen injectors accounted for 24.0% of the pre-filled syringe market. Leading suppliers of autoinjectors include Ypsomed, Owen Mumford, SHL Group and BD. The rising incidence of diabetes, as well as other chronic diseases, worldwide and the increased demand for drugs that can be administered in the home healthcare setting will stimulate demand for pre-filled drug dispensing products over the coming 10 years. Syringe manufacturers must ensure that new products meet the demands of patients, healthcare professionals and drug developers.

Expansion of the pre-filled syringe industry and market also offers opportunities to medical device component manufacturers, especially companies making plungers, needle shields and tip caps. The three leading companies in that sector, Datwyler, West and Stelmi, control significant market share as a result of partnerships with leading drug and syringe manufacturers. Top Pre-Filled Syringe Manufacturers: Market Outlook 2012-2022 adds to visiongain's range of analytical reports on industries and markets in healthcare.

To see an executive summary of this report please email sara.peerun@visiongainglobal.com

Companies mentioned in this report include:

Companies Listed

Abbott Laboratories
Alfamatic (part of the Stevanato Group)
American Stelmi
Amgen
Amylin Pharmaceuticals
Antares Pharma
B. Braun
Baxter BioPharma Solutions (part of Baxter International)
Baxter International
Bayer
Becton, Dickinson & Co (BD)
Biogen Idec
Boehringer Ingelheim
Cambridge Consultants
Carmel Pharma
Catalent
CeifiT
Daikyo Seiko
Datwyler Group
Diagenode
Disetronic Group (now part of Roche)
Dongbao
DS WorldMed
Eisai
Elan
Eli Lilly
European Medicines Agency (EMA)
Food and Drug Administration (FDA) [US]
Genentech (now part of Roche)
Generex
Gerresheimer
Gerresheimer Bünde (subsidiary of Gerresheimer)
GSK
Harvard University
Inhibitex
Insulet
J&J
La Model (now part of West)
Ligocyte Pharmaceuticals
Medical Glass (part of the Stevanato Group)
MedImmune
Medimop Medical Projects (now part of West)
MedPro Safety Products
Merck & Co.
Merck Serono (also Merck KGaA)
MG Sterile Products
MGlas
MGlas Scandinavia (formerly Pharmapack Packaging Systems)
Ministry of Health [Brazil]
Momenta
Mylan
Naigai Glass Industry Co
Natco
Nektar Therapeutics
Nippon Zeon Co
Novartis
Novo Nordisk
Nuova Ompi (part of the Stevanato Group)
Nycomed (now part of Takeda)
Ompi of America (part of the Stevanato Group)
Optrel (subsidiary of Spami)
Otsuka Pharmaceutical
Owen Mumford
PATH
Pertinax (now part of SHL Group)
Pfizer
Pharma-Pen (now part of West)
PharmaPraxis
Pharmasset
Pharmstandard
Plastef Investissements
Polfa Tarchomin
Revolutions Medical
Roche
Rumpler Technologies
Safety Syringes
Sandoz
Sanofi
Sanofi Pasteur (part of Sanofi)
Schering-Plough (now part of Merck & Co.)
Schott
SHL Group
Spami (part of the Stevanato Group)
Stelmi
Stelmi Asia
Stevanato Group
Taisei Kako Co
Teva Pharmaceutical Industries
tip-top
Tonghua Dongbao Pharmaceutical Co
Unilife
University of Colorado
US Agency for International Development (USAID)
Védat (now part of Gerresheimer)
Vertex Pharmaceuticals
Vetter Pharma
Watson Pharmaceuticals
West Company Mexico (subsidiary of West)
West Pharmaceutical Services
Ypsomed and its subsidiaries:
DiaExpert
feelfree
Ypsomed AB
Ypsomed BV
Ypsomed Distribution
Ypsomed GmbH
Ypsomed India Private Ltd
Ypsomed Ltd
Ypsomed SAS
Ypsotec
Ypsotec s.r.o.
Zhejiang Xinkang Pharmaceutical Glass Co 

Notes for Editors

About visiongain

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on. 

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44(0)207-336-6100